NEW YORK — Lab Genomics has signed a distribution agreement to offer Contextual Genomics' Follow It next-generation sequencing-based cancer genomic assay in Southern California and certain other parts of the US, the companies announced on Monday.
Specific terms of the deal were not disclosed.